LONDON, April 16 - Shire, the London - listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to
unlisted French drugmaker Servier for $ 2.4 billion.
Not exact matches
Frerot said that Veolia could not bid for
unlisted smaller
French competitor Saur if it were to be sold because of antitrust reasons.
The
French Government has cleared the way for the use of blockchain technology in the trading of
unlisted securities, as it rewrites is rules to stimulate the innovation economy.